Home / Health / Alarming Trend: 1 in 4 Canadian Seniors on Antipsychotics
Alarming Trend: 1 in 4 Canadian Seniors on Antipsychotics
28 Feb
Summary
- Nearly 24% of Canadian long-term care residents got antipsychotics unnecessarily.
- These potent drugs carry serious risks including death and cognitive decline.
- National target of 15% or less for inappropriate use remains unmet.
As of February 28, 2026, a significant portion of Canada's long-term care residents, nearly 24%, are being prescribed potent antipsychotic medications without a psychosis diagnosis. These drugs, such as Haldol and Risperidone, are intended for conditions like schizophrenia but are sometimes used for dementia-related aggression.
However, their inappropriate use poses serious risks, including adverse reactions, cognitive decline, falls, and increased mortality, according to the Canadian Institute for Health Information (CIHI). This rate is stubbornly high and exceeds national targets, with some provinces showing significantly higher percentages of potentially unnecessary prescriptions.
Experts note that while the pandemic disrupted priorities, the focus must return to reducing this potentially inappropriate use. Alternative strategies, such as addressing underlying issues like pain and utilizing non-pharmacological interventions, are recommended. Regular medication reviews are also suggested to ensure continued necessity and appropriate dosing.
